SEC Filing Summary: Hemispherx Biopharma, Inc. (8-K)
Business Context and Reporting Period
This Form 8-K was filed on September 13, 2018, by Hemispherx Biopharma, Inc. (Note: The request metadata lists "AIM Immunotech Inc.", but the filing text explicitly identifies the registrant as Hemispherx Biopharma, Inc.). The report details the results of the Company's 2018 Annual Meeting of Stockholders held on September 12, 2018. A quorum of 40.0% was present at the meeting.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting outcomes rather than financial performance.
Material Changes and Voting Results
Stockholders voted on several key matters. The results were as follows:
- Election of Directors: All three nominees (Thomas K. Equels, William M. Mitchell, Stewart L. Appelrouth) received significant "For" votes, though substantial broker non-votes were recorded for each.
- Ratification of Independent Accountants: Morrison, Brown, Argiz & Farra, LLC was ratified with 23,397,400 votes "For" versus 1,088,279 "Against".
- Executive Compensation (Say-on-Pay): The advisory vote on Named Executive Officer compensation passed with 5,422,897 "For" votes against 1,325,480 "Against".
- 2018 Equity Incentive Plan: Approved with 4,807,712 "For" votes against 1,944,762 "Against".
- Name Change: The proposal to change the Company's name was approved with 20,324,225 "For" votes against 3,974,825 "Against".
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, or contingencies beyond the standard disclosure of voting results.
Key Facts for Investor Verification
- Verify the new corporate name following the approved name change resolution.
- Confirm the implementation details of the newly approved 2018 Equity Incentive Plan.
- Review the composition of the Board of Directors following the election of the three nominees.
- Check subsequent filings for the official announcement of the name change effective date.